Disparities in Initiation of Direct-Acting Antiviral Agents for Hepatitis C Virus Infection in an Insured Population

OBJECTIVES: The cost of direct-acting antiviral agents (DAAs) for hepatitis C virus (HCV) infection may contribute to treatment disparities. However, few data exist on factors associated with DAA initiation. METHODS: We conducted a retrospective cohort study of HCV-infected Kaiser Permanente Norther...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Pubblicato in:Public Health Rep
Autori principali: Marcus, Julia L., Hurley, Leo B., Chamberland, Scott, Champsi, Jamila H., Gittleman, Laura C., Korn, Daniel G., Lai, Jennifer B., Lam, Jennifer O., Pauly, Mary Pat, Quesenberry, Charles P., Ready, Joanna, Saxena, Varun, Seo, Suk I., Witt, David J., Silverberg, Michael J.
Natura: Artigo
Lingua:Inglês
Pubblicazione: SAGE Publications 2018
Soggetti:
Research
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC6055302/
https://ncbi.nlm.nih.gov/pubmed/29750893
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1177/0033354918772059
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi